Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group (Q33357719)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group |
scientific article |
Statements
1 reference
Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group (English)
1 reference
T Baetz
1 reference
A Belch
1 reference
S Couban
1 reference
K Imrie
1 reference
J Yau
1 reference
R Myers
1 reference
K Ding
1 reference
N Paul
1 reference
L Shepherd
1 reference
J Iglesias
1 reference
R Meyer
1 reference
M Crump
1 reference
1 December 2003
1 reference
1 reference
14
1 reference
12
1 reference
1762-1767
1 reference
Identifiers
1 reference
1 reference